192 related articles for article (PubMed ID: 7682266)
1. Comparison of two aprotinin dosage regimens in pediatric patients having cardiac operations. Influence on platelet function and blood loss.
Boldt J; Knothe C; Zickmann B; Wege N; Dapper F; Hempelmann G
J Thorac Cardiovasc Surg; 1993 Apr; 105(4):705-11. PubMed ID: 7682266
[TBL] [Abstract][Full Text] [Related]
2. Aprotinin in pediatric cardiac operations: platelet function, blood loss, and use of homologous blood.
Boldt J; Knothe C; Zickmann B; Wege N; Dapper F; Hempelmann G
Ann Thorac Surg; 1993 Jun; 55(6):1460-6. PubMed ID: 7685588
[TBL] [Abstract][Full Text] [Related]
3. [Reduction of postoperative blood loss and donor blood use in heart surgery with aprotinin: experience with various dosages].
Carrel T; Bauer E; Garcia E; von Segesser L; Niederhäuser U; Schönbeck M; Laske A; Turina M
Helv Chir Acta; 1991 Sep; 58(3):365-78. PubMed ID: 1722785
[TBL] [Abstract][Full Text] [Related]
4. Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operation.
Verma YS; Chauhan S; Bisoi AK; Gharde P; Kiran U; Das SN
Ann Card Anaesth; 2010; 13(2):110-5. PubMed ID: 20442540
[TBL] [Abstract][Full Text] [Related]
5. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
[TBL] [Abstract][Full Text] [Related]
6. Aprotinin prevents cardiopulmonary bypass-induced platelet dysfunction. A scanning electron microscope study.
Mohr R; Goor DA; Lusky A; Lavee J
Circulation; 1992 Nov; 86(5 Suppl):II405-9. PubMed ID: 1385010
[TBL] [Abstract][Full Text] [Related]
7. Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations.
Dietrich W; Mössinger H; Spannagl M; Jochum M; Wendt P; Barankay A; Meisner H; Richter JA
J Thorac Cardiovasc Surg; 1993 Apr; 105(4):712-20. PubMed ID: 7682267
[TBL] [Abstract][Full Text] [Related]
8. Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass.
Blauhut B; Gross C; Necek S; Doran JE; Späth P; Lundsgaard-Hansen P
J Thorac Cardiovasc Surg; 1991 Jun; 101(6):958-67. PubMed ID: 1710008
[TBL] [Abstract][Full Text] [Related]
9. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass.
van Oeveren W; Harder MP; Roozendaal KJ; Eijsman L; Wildevuur CR
J Thorac Cardiovasc Surg; 1990 May; 99(5):788-96; discussion 796-7. PubMed ID: 1691806
[TBL] [Abstract][Full Text] [Related]
10. Platelet function during cardiopulmonary bypass not changed by two different doses of aprotinin.
Santamaría A; Mateo J; Muñíz-Díaz E; Oliver A; Murillo J; Litvan H; Souto JC; Fontcuberta J
Haematologica; 2000 Apr; 85(4):381-5. PubMed ID: 10756363
[TBL] [Abstract][Full Text] [Related]
11. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
12. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
Alvarez JM; Jackson LR; Chatwin C; Smolich JJ
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
[TBL] [Abstract][Full Text] [Related]
13. A point-of-care assessment of the effects of desmopressin on impaired platelet function using multiple electrode whole-blood aggregometry in patients after cardiac surgery.
Weber CF; Dietrich W; Spannagl M; Hofstetter C; Jámbor C
Anesth Analg; 2010 Mar; 110(3):702-7. PubMed ID: 20042444
[TBL] [Abstract][Full Text] [Related]
14. Postoperative aprotinin: effect on blood loss and transfusion requirements in cardiac operations.
Ciçek S; Demirkiliç U; Kuralay E; Ozal E; Tatar H
Ann Thorac Surg; 1996 May; 61(5):1372-6. PubMed ID: 8633944
[TBL] [Abstract][Full Text] [Related]
15. The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss.
Santamaría A; Mateo J; Oliver A; Litvan H; Murillo J; Souto JC; Fontcuberta J
Haematologica; 2000 Dec; 85(12):1277-84. PubMed ID: 11114135
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of a cell saver and low-dose aprotinin on blood loss and homologous blood usage in patients undergoing valve surgery.
Tempe DK; Banerjee A; Virmani S; Mehta N; Panwar S; Tomar AS; Ghambeer DK; Nigam M
J Cardiothorac Vasc Anesth; 2001 Jun; 15(3):326-30. PubMed ID: 11426363
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of the preserving effect of aprotinin on platelet function and its use in cardiac surgery.
Huang H; Ding W; Su Z; Zhang W
J Thorac Cardiovasc Surg; 1993 Jul; 106(1):11-8. PubMed ID: 7686594
[TBL] [Abstract][Full Text] [Related]
18. Platelet function in cardiac surgery: influence of temperature and aprotinin.
Boldt J; Knothe C; Zickmann B; Bill S; Dapper F; Hempelmann G
Ann Thorac Surg; 1993 Mar; 55(3):652-8. PubMed ID: 7680852
[TBL] [Abstract][Full Text] [Related]
19. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol).
Bidstrup BP; Royston D; Sapsford RN; Taylor KM
J Thorac Cardiovasc Surg; 1989 Mar; 97(3):364-72. PubMed ID: 2465457
[TBL] [Abstract][Full Text] [Related]
20. Influence of different anticoagulation regimens on platelet function during cardiac surgery.
Boldt J; Schindler E; Osmer C; Wittstock M; Stertmann WA; Hempelmann G
Br J Anaesth; 1994 Nov; 73(5):639-44. PubMed ID: 7530029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]